Efficacy of Nimodipine Plus Yufeng Ningxin Tablets for Patients with Frequent Migraine

<b><i>Background/Aims:</i></b> To test the effects of Nimodipine plus Yufeng Ningxin tablets on frequent migraine. <b><i>Methods:</i></b> Two hundred forty-two patients with frequent migraine were divided into the control group with those consuming Flunarizine (120 cases) and the treatment group with those consuming Nimodipine plus Yufeng Ningxin tablets (122 cases). The course of frequent migraine treatment lasted 7 weeks. The number of migraine days, visual analogue scale (VAS) score, and response rate were measured. <b><i>Results:</i></b> There was significant difference in the cure rate as the Nimodipine plus Yufeng Ningxin tablets group compared with the Flunarizine group (78.7 vs. 21.7%; <i>p</i> &#x3c; 0.001). Fewer migraine days and VAS score were observed in the treatment group when compared with the control group (<i>p</i> &#x3c; 0.05). Nimodipine plus Yufeng Ningxin tablets were superior to Flunarizine in terms of the response rate at week 7 (<i>p</i> &#x3c; 0.05). <b><i>Conclusion:</i></b> Due to its high cure rate, treatment with Nimodipine plus Yufeng Ningxin tablets is recommended to control frequent migraine, and this hypothesis needs to be confirmed through further studies conducted on a more extensive population.